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background: The chronic inflammatory disorder psoriasis (PSO) increases cardiovascular disease (CVD) susceptibility beyond traditional CV risk 
factors, yet mediators of elevated risk in PSO are largely unknown. Cardiometabolic disease (CMD) is a prominent feature of PSO, however there 
is little data on how obesity, insulin resistance and HDL dysfunction contribute to the development of CVD in PSO. Therefore, this study aimed to 
understand whether incorporating measures of CMD on top of traditional risk factors increased measures of vascular inflammation in PSO.
methods: We utilized 18-flurodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) scans to quantify aortic 
vascular inflammation, which has been shown to predict future CV events. Relationships between vascular inflammation (defined as maximum 
aortic standardized uptake value [SUVmax]) and measures of obesity (BMI), insulin resistance (HOMA-IR) and HDL dysfunction (HDL efflux) were 
established in a longitudinal study of CV risk predictors in chronic inflammation (NCT01778569). BMI, HOMA-IR and HDL efflux were used to 
calculate a CMD risk score (CMS), and then regression was used to understand relationships between aortic SUVmax and measures of CMD during a 
single baseline visit in 2012-2013 (n=42). Likelihood ratio testing was done to calculate incremental contribution of CMD beyond Framingham Risk 
Score (FRS) in vascular inflammation.
results: There were significant associations between CMS and FRS (β 0.134, p<0.001), FRS and aortic SUVmax (β 0.119, p <0.001) and CMS 
and aortic SUVmax (β 0.409, p<0.001). After adjusting for age, sex, diabetes, hypertension, hyperlipidemia, tobacco and alcohol use, a each higher 
value of CMD score was associated with increased vascular inflammation (RR 1.5-fold, p<0.001). Together, BMI, HOMA-IR and HDL efflux predicted 
increased vascular inflammation beyond FRS and traditional CV risk factors (χ2 82, p<0.0001).
conclusions:  Measures of obesity, insulin resistance and lipid metabolism independently predict vascular disease in PSO. These parameters may 
serve as powerful indicators of CV risk in this population.
